{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:39:31Z","timestamp":1774867171706,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1002\/jps.21335","type":"journal-article","created":{"date-parts":[[2008,2,25]],"date-time":"2008-02-25T17:17:11Z","timestamp":1203959831000},"page":"4889-4903","source":"Crossref","is-referenced-by-count":65,"title":["Brain uptake of an anti-ischemic agent by nasal administration of microparticles"],"prefix":"10.1016","volume":"97","author":[{"given":"Alessandro","family":"Dalpiaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Gavini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Bortolotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Tanganelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Scatturin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enea","family":"Menegatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Giunchedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.21335_bb0010","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/0929867023368917","article-title":"Adenosine A1 receptor: Analysis of the potential therapeutic effects obtained by its activation in the central nervous system","volume":"9","author":"Dalpiaz","year":"2002","journal-title":"Curr Med Chem"},{"key":"10.1002\/jps.21335_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0304-3940(94)90756-0","article-title":"Adenosinergic modulation of CA1 neuronal tolerance to glucose deprivation in organotypic hippocampal cultures","volume":"178","author":"Hsu","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1002\/jps.21335_bb0020","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1471-4159.1992.tb10041.x","article-title":"Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: Effects of adenosine receptor agonists and antagonists","volume":"58","author":"Simpson","year":"1992","journal-title":"J Neurochem"},{"key":"10.1002\/jps.21335_bb0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0014-2999(99)00073-4","article-title":"Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist","volume":"369","author":"von Lubitz","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/jps.21335_bb0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(99)00135-1","article-title":"Adenosine and cerebral ischemia: Therapeutic future or death of a brave concept?","volume":"371","author":"von Lubitz","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/jps.21335_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0006-8993(87)90214-9","article-title":"Central versus peripheral mediation of responses to adenosine receptor agonists: Evidence against a central mode of action","volume":"415","author":"Brodie","year":"1987","journal-title":"Brain Res"},{"key":"10.1002\/jps.21335_bb0040","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D","article-title":"Transporter\u2010mediated permeation of drugs across the blood\u2010brain barrier","volume":"89","author":"Tamai","year":"2000","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21335_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejps.2004.09.010","article-title":"Brain penetration of synthetic A1 receptor agonists in situ: Role of the rENT1 nucleoside transporter and binding to blood constituents","volume":"24","author":"Schaddelee","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.21335_bb0050","first-page":"113, 120","article-title":"High\u2010performance liquid chromatography of the adenosine A1 agonist N6\u2010cyclopentyladenosine and the A1 antagonist 8\u2010cyclopentyltheophylline and its application in a pharmacokinetic study in rats","volume":"620","author":"Mathot","year":"1993","journal-title":"J Chromatogr"},{"key":"10.1002\/jps.21335_bb0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0168-3659(01)00293-0","article-title":"Poly(lactic acid) microspheres for the sustained release of a selective A1 receptor agonist","volume":"73","author":"Dalpiaz","year":"2001","journal-title":"J Control Release"},{"key":"10.1002\/jps.21335_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0922-4106(94)90224-0","article-title":"Full and partial agonistic behaviour and thermodynamic binding parameters of adenosine A1 receptor ligands","volume":"267","author":"Borea","year":"1994","journal-title":"Eur J Pharmacol Mol Pharmacol Sect"},{"key":"10.1002\/jps.21335_bb0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/BF00169369","article-title":"Partial agonism of theophylline\u20107\u2010riboside on adenosine receptors","volume":"350","author":"IJzerman","year":"1994","journal-title":"Naunyn\u2010Schmiedeberg's Arch Pharmacol"},{"key":"10.1002\/jps.21335_bb0070","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjp.0701868","article-title":"Selectivity of action of 8\u2010alkylamino analogues of N6\u2010cyclopentyladenosine in vivo: Haemodynamic versus anti\u2010lipolytic responses in rats","volume":"124","author":"van Schaick","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1002\/jps.21335_bb0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jps.2600830112","article-title":"Adenosine receptor prodrugs:Synthesis and biological activity of derivatives of potent A1\u2010selective agonists","volume":"83","author":"Maillard","year":"1994","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21335_bb0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/A:1011018730459","article-title":"Synthesis and study of 5\u2032\u2010ester prodrugs of N6\u2010cyclopentyladenosine, a selective A1 receptor agonist","volume":"18","author":"Dalpiaz","year":"2001","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21335_bb0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(02)00179-5","article-title":"Poly (lactic acid) microspheres for the sustained release of antiischemic agents","volume":"242","author":"Dalpiaz","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21335_bb0090","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.biomaterials.2004.04.033","article-title":"Development and characterization of biodegradable nanoparticles as delivery systems of antiischemic adenosine derivatives","volume":"26","author":"Dalpiaz","year":"2005","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21335_bb0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2005.09.031","article-title":"Nanoparticle formulation may affect the stabilization of an antiischemic prodrug","volume":"307","author":"Leo","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21335_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.21335_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1567201053586047","article-title":"Intranasal drug delivery for brain targeting","volume":"2","author":"Vyas","year":"2005","journal-title":"Curr Drug Del"},{"key":"10.1002\/jps.21335_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357022539","article-title":"Is nose\u2010to\u2010brain transport of drugs in man a reality?","volume":"56","author":"Illum","year":"2004","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.21335_bb0115","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","article-title":"Delivery of neurotropic factors to the central nervous system","volume":"40","author":"Thorne","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.21335_bb0120","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1248\/bpb.17.1135","article-title":"Nasal adsorption of zidovudine and its transport to cerebrospinal fluid in rats","volume":"17","author":"Seki","year":"1994","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.21335_bb0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5173(98)00061-1","article-title":"The distribution of local anesthetics into the CSF following intranasal administration","volume":"168","author":"Chou","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21335_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0378-5173(98)00170-7","article-title":"Lidocaine distribution into the CNS following nasal and arterial delivery: A comparison of local sampling and microdialysis techniques","volume":"171","author":"Chou","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21335_bb0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1099-081X(199705)18:4<335::AID-BDD22>3.0.CO;2-W","article-title":"Distribution of antihistamines into the CSF following the intranasal delivery","volume":"18","author":"Chou","year":"1997","journal-title":"Biopharm Drug Disp"},{"key":"10.1002\/jps.21335_bb0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijpharm.2005.06.012","article-title":"Transport of hydroxyzine and tripolidine across bovine olfactory mucosa: Role of passive diffusion in the direct nose\u2010to\u2010brain uptake of small molecules","volume":"302","author":"Kandimalla","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21335_bb0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.2042-7158.1991.tb03510.x","article-title":"Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity","volume":"43","author":"Sakane","year":"1991","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.21335_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0928-0987(01)00151-8","article-title":"Levels of dopamine in blood and brain following nasal administration to rats","volume":"14","author":"Dahlin","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.21335_bb0155","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin\u2010like growth factor\u2010I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1002\/jps.21335_bb0160","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.301.1.391","article-title":"Intranasal delivery of morphine","volume":"301","author":"Illum","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21335_bb0165","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1002\/jps.20604","article-title":"Primari microparticles and agglomerates of morphine for nasal insufflation","volume":"95","author":"Russo","year":"2006","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21335_bb0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2165\/00003088-199223010-00003","article-title":"Intranasal insulin. Clinical paharmacokinetics","volume":"23","author":"Illum","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.21335_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(00)00540-9","article-title":"Manipulating neuropeptidergic parhways in humans: A novel approach to neuropharmacology?","volume":"405","author":"Fehm","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/jps.21335_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0939-6411(03)00155-3","article-title":"Chitosan\u2010DNA nanoparticles as non\u2010viral vectors in gene therapy: Strategies to improve transfection efficacy","volume":"57","author":"Mansouri","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.21335_bb0185","series-title":"Physical pharmacy","first-page":"423","article-title":"Micrometrics","author":"Martin","year":"1993"},{"key":"10.1002\/jps.21335_bb0190","first-page":"23","article-title":"Studies of PLGA microspheres","volume":"16","author":"Dubey","year":"2004","journal-title":"Pharm Tech Eur"},{"key":"10.1002\/jps.21335_bb0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(97)00063-X","article-title":"Effects of physicochemical properties and other factors on systemic nasal drug delivery","volume":"29","author":"Behl","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.21335_bb0200","first-page":"203","article-title":"Spray dried albumin microspheres containing nicardipine","volume":"40","author":"Conte","year":"1994","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.21335_bb0205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1211\/0022357055623","article-title":"Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: In vitro\/Ex vivo studies","volume":"57","author":"Gavini","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.21335_bb0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0378-5173(02)00177-1","article-title":"Caffeine microparticles for nasal administration obtained by spray drying","volume":"242","author":"Sacchetti","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21335_bb0215","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0006-2952(98)00270-6","article-title":"Processing of adenosine receptor agonists in rat and human whole blood","volume":"56","author":"Pavan","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/jps.21335_bb0220","first-page":"276","article-title":"Spray\u2010drying as a preparation method of microparticulate drug delivery system: An overwiew","volume":"5","author":"Giunchedi","year":"1995","journal-title":"STP Pharma Sci"},{"key":"10.1002\/jps.21335_bb0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2006.12.014","article-title":"Evaluation of bioadhesive polymers as delivery systems foe nose to brain delivery: In vitro characterisation studies","volume":"118","author":"Charlthon","year":"2007","journal-title":"J Control Release"},{"key":"10.1002\/jps.21335_bb0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-5173(92)90353-4","article-title":"In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers","volume":"78","author":"Leher","year":"1992","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21335_bb0235","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1021\/cr030441b","article-title":"Chitosan chemistry and pharmaceutical perspectives","volume":"104","author":"Ravi Kumar","year":"2004","journal-title":"Chem Rev"},{"key":"10.1002\/jps.21335_bb0240","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1023\/A:1016418523014","article-title":"Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles","volume":"19","author":"Dyer","year":"2002","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21335_bb0245","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1023\/A:1018908705446","article-title":"Enhancement of nasal absorption of insulin using chitosan nanoparticles","volume":"16","author":"Fernandez\u2010Urrusuno","year":"1999","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21335_bb0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-3659(99)00285-0","article-title":"Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan","volume":"66","author":"Lim","year":"2000","journal-title":"J Control Release"},{"key":"10.1002\/jps.21335_bb0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(01)00873-0","article-title":"In vivo evaluation of novel hyaluronan\/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits","volume":"231","author":"Lim","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21335_bb0260","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0169-409X(93)90015-V","article-title":"The relevance of nasal physiology to the design of drug absorption studies","volume":"11","author":"Gizurarson","year":"1993","journal-title":"Adv Drug Del Rew"},{"key":"10.1002\/jps.21335_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357011775145","article-title":"The biopharmaceutical aspects of nasal mucoadhesive drug delivery","volume":"53","author":"Ugwoke","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.21335_bb0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-510X(01)00532-9","article-title":"Intranasal administration of insulin\u2010like growth factor\u2010I bypasses the blood\u2010brain barrier and protects against focal cerebral ischemic damages","volume":"187","author":"Liu","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1002\/jps.21335_bb0275","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(01)01982-6","article-title":"Non\u2010invasive intranasal insulin\u2010like growth factor\u2010I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion","volume":"308","author":"Liu","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1002\/jps.21335_bb0280","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.2741\/2443","article-title":"Intranasal administration of a PARG inhibitor profoundly decreases ischemic brain injury","volume":"12","author":"Wei","year":"2007","journal-title":"Front Biosci"},{"key":"10.1002\/jps.21335_bb0285","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery\u2014Possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J Control Release"},{"key":"10.1002\/jps.21335_bb0290","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0165-0270(02)00033-X","article-title":"Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity","volume":"116","author":"van der Berg","year":"2002","journal-title":"J Neurosci Mehods"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916327708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916327708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T04:47:26Z","timestamp":1557290846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916327708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0022354916327708"],"URL":"https:\/\/doi.org\/10.1002\/jps.21335","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}